NAMI NEW JERSEY ADVOCACY E-NEWS

September 7, 2007

ADVOCACY NEWS FROM NAMI NEW JERSEY:

1. BIPOLAR ILLNESS SOARS AS A DIAGNOSIS FOR THE YOUNG
2. AMERICAN GIRLS' SUICIDE RATES SPIKE
3. NEW SCHIZOPHRENIA DRUG SHOWS PROMISE IN TRIALS
4. DEPRESSION MORE HARMFUL, SAYS STUDY
5. SOUTH JERSEY RESIDENT SHOT DEAD BY TROOPER
6. AUTOPSY YIELDS FEW ANSWERS FOR FAMILY

***********************************************

BIPOLAR ILLNESS SOARS AS A DIAGNOSIS FOR THE YOUNG

The number of American children and adolescents treated for bipolar disorder increased 40-fold from 1994 to 2003, researchers report today in the most comprehensive study of the controversial diagnosis. Experts say the number has almost certainly risen further since 2003. Many experts theorize that the jump reflects that doctors are more aggressively applying the diagnosis to children, and not that the incidence of the disorder has increased. But the magnitude of the increase surprises many psychiatrists. They say it is likely to intensify the debate over the validity of the diagnosis, which has shaken child psychiatry.

Read the NY Times report (free to register)

***********************************************

AMERICAN GIRLS' SUICIDE RATES SPIKE

The suicide rate among preteen and young teen girls spiked dramatically in a disturbing shift that federal health officials say they can't fully explain. For all young people between ages 10 to 24, the suicide rate rose 8 percent from 2003 to 2004 — the biggest single-year bump in 15 years — in what one official called "a dramatic and huge increase."

The report, based on the latest numbers available, was released Thursday by the Centers for Disease Control and Prevention and suggests a troubling reversal in recent trends. Suicide rates had fallen by 28.5 percent since 1990 among young people.

Read the Associated Press story:
http://ap.google.com/article/ALeqM5iqbNkWQufq1RvybGGAbs9nRTZdSA

The CDC Report:
http://www.cdc.gov/ncipc/dvp/suicide

***********************************************

NEW SCHIZOPHRENIA DRUG SHOWS PROMISE IN TRIALS

In a clinical trial of about 200 patients, an experimental drug from Eli Lilly reduced schizophrenia symptoms without the serious side effects of current treatments, according to a paper published in the journal Nature. The drug must still be evaluated on many more patients to test for the possibility of side effects that have not yet emerged, and it is at least three to four years from completing regulatory review. But schizophrenia researchers said the trial’s results were surprising and impressive, especially since the drug works in a different way from existing antipsychotic medicines, all of which have serious side effects, including substantial weight gain and tremors.

Read the NY Times report (free to register)

***********************************************

DEPRESSION MORE HARMFUL THAN ANGINA, SAYS STUDY

Depression can do more physical damage to a person's health than several long-term diseases, according to a World Health Organisation study published in the Lancet. Results showed that depression had more impact on sufferers than angina, arthritis, asthma, and diabetes.

"On the basis of our results, addressing the further exacerbation of disability due to depression needs to be a priority of health systems worldwide," wrote Dr Moussavi. "Primary care providers must be taught not to ignore the presence of depression when patients present with a chronic physical condition."

He said that this would only be achieved by reducing the stigma around mental illness and alerting doctors and the public at large that depression was a disease at least on a par with physical chronic diseases in damaging health.

Read more:
http://www.guardian.co.uk/science/2007/sep/07/medicineandhealth.lifeandhealthinsurance

***********************************************

SOUTH JERSEY RESIDENT SHOT DEAD BY TROOPER

A state trooper fatally shot a 51-year-old man early yesterday after he walked out of the bedroom of his South Jersey home carrying two long guns and pointed one of them at troopers, the Attorney General's Office said. The incident is being investigated by the attorney general's shooting response team, which looks into shootings involving police officers statewide.

Troopers initially went to the Salem County home after getting a report that a man was behaving erratically, only to leave minutes later after being told that he had calmed down, authorities said. His son called the State Police again about six hours later, this time to report that Nelson had ingested a large number of pills and was suicidal, authorities said. When troopers arrived, they found him holding a handgun to his head.

Read more:
http://www.nj.com/news/ledger/jersey/index.ssf?/base/news-8/118914162159770.xml&coll=1

***********************************************

AUTOPSY YIELDS FEW ANSWERS FOR FAMILY
Toxicology pending for Greystone patient

The results of an autopsy done on a 38-year-old Greystone Park Psychiatric Hospital patient who died two weeks ago were "inconclusive" and it will be at least a month before results of toxicological tests on the Jersey City man are known, officials said.This was the fourth death at Greystone this year, including two "unexpected deaths," according to state records. A 34-year-old patient, died in late June. Preliminary autopsy results showed his death was likely due to natural causes, but results of toxicology tests have yet to be released.

Read Lawrence Ragonese’s Report:
http://www.nj.com/news/ledger/morris/index.ssf?/base/news-3/118905469118220.xml&coll=1
 


NAMI NEW JERSEY, the State's voice on mental illness, is a statewide coalition of self-help support and advocacy groups composed of families and friends of persons with a serious mental illness. With chapters in all 21 counties we are New Jersey's largest grassroots organization dedicated to improving the quality of life of individuals who have a serious mental illness and their families.


Please distribute this Alert to other advocates for improved mental health services in New Jersey.  If you would like to receive NAMI NEW JERSEY Advocacy Alerts by email, contact Phil Lubitz, Director of Advocacy Programs at advocacy@naminj.org or by phone 732-940-0991.
 

 

NAMI NEW JERSEY
1562 Route 130, North Brunswick, New Jersey 08902
Phone:732.940.0991 Fax:732.940.0355
E-mail: info@naminj.org
Web Address: www.naminj.org
Copyright © 2007 NAMI NEW JERSEY - All Rights Reserved